Global Cell Line Development Market to Reach $14.7 Billion by 2030
January 05, 2024 22:38 ET
|
Research and Markets
Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The "Cell Line Development: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cell Line...
Kymanox Unveils Product Design, Development, and Commercialization Group Under Leadership of Chief Technology Officer
January 04, 2024 10:30 ET
|
Kymanox
Morrisville, North Carolina USA, and King of Prussia, Pennsylvania USA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Kymanox Corporation (“Kymanox”), a professional services company exclusively serving Life...
Biologics Market Report 2024-2034 - Advances in Regenerative Medicine and Cell Biology Driving Market Growth
December 28, 2023 04:48 ET
|
Research and Markets
Dublin, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The "Biologics Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering. Revenue for the Biologics Market is forecast to surpass...
Global Biologics Drug Discovery Market Analysis, 2023-2033: Dominated by AbbVie, Amgen, AstraZeneca, and Pfizer
December 19, 2023 12:08 ET
|
Research and Markets
Dublin, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The "Biologics Drug Discovery Market - A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The dynamic...
Europe Wound Biologics Market Insights Report 2023-2028: Specialty Wound Clinics Accounted for the Highest Share of 54.33% in 2022
December 07, 2023 05:18 ET
|
Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "Europe Wound Biologics Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. European wound biologics...
Global Biologics CDMO Market Research Report 2023-2033: Biologics Revolutionizes Treatments, Complex Biologic Molecules Drive Demand for CDMO Services
December 06, 2023 03:23 ET
|
Research and Markets
Dublin, Dec. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Biologics CDMO Market - A Global and Regional Analysis, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The global...
United States Wound Biologics Market Insights 2023-2028: with Avita Medical, Organogenesis, Smith+Nephew, Vericel, and Orthofix Dominating
November 22, 2023 10:18 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "US Wound Biologics Market - Focused Insights 2023-2028" report has been added to ResearchAndMarkets.com's offering. US wound biologics market was...
North America Leads the Charge in the Booming Biologics CDMO Market with Projected Growth from $6.6 Billion in 2023 to $12.4 Billion by 2028
November 08, 2023 05:33 ET
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Biologics Contract Development and Manufacturing Organizations (CDMOs): Global Markets" report has been added to ResearchAndMarkets.com's offering. ...
Global Regenerative Medicine Partnering Deal Terms and Agreements Analysis Report 2023 with Directory of 1,700+ Deals Singed Since 2016
November 07, 2023 05:03 ET
|
Research and Markets
Dublin, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.com's offering. The Global...
Rate of Switching from Regeneron’s Eylea to Genentech’s Vabysmo Doubled Over Past Year for Diabetic Macular Edema
November 01, 2023 14:55 ET
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 01, 2023 (GLOBE NEWSWIRE) -- As U.S. ophthalmologists increasingly embrace a wider array of treatment options, the landscape of the diabetic macular edema (DME) market has...